ÂÜÀòÂÒÂ×

Paul Nguyen currently serves as a Medical Advisor at Nanocan Therapeutics Corporation and has held the position of Director of Genitourinary Radiation Oncology, Professor, and Vice-Chair of Clinical Research at Dana-Farber Cancer Institute since July 2005, specializing in prostate cancer. Additionally, Paul Nguyen has been a Radiation Oncology Resident and Professor of Radiation Oncology at Harvard Medical School since 2009. Previous roles include medical advisory positions at Boston Scientific and Augmenix and residency at Massachusetts General Hospital. Early career experiences include an internship at Brigham and Women's Hospital and roles at The Boston Consulting Group and Harvard Business School. Paul Nguyen earned an MBA from MIT Sloan School of Management, an MD from Harvard Medical School, and an A.B. in Philosophy from Harvard University.